Superficial cervical plexus block may be safe and effective for use in emergency medicine.
In patients with subacromial pain syndrome, ultrasound-guided percutaneous electrolysis plus standard therapy and exercise may not bring additional benefits in terms of disability and pressure sensitivity compared with therapy and exercise alone.
Application of force to C5 using a mechanically assisted instrument may improve internal rotation strength and frequency but not severity of extreme shoulder pain.
Investigators sought to determine whether phrenic nerve infiltration and suprascapular nerve block would control acute ipsilateral shoulder pain after thoracotomy.
Arthroscopic subacromial decompression may not improve pain relative to placebo surgery or provide clinically important benefits compared with no treatment in patients with subacromial shoulder pain.
Corticosteroid injections may be associated with greater efficacy in the short-term compared with local anesthetic injections in the treatment of rotator cuff-related shoulder pain.
Surgical intervention with arthroscopic subacromial decompression may not yield a clinically significant reduction in shoulder pain and function in patients with subacromial pain.
No difference in outcomes was found between a single- and a double-needle ultrasonography-guided percutaneous irrigation in patients with calcific tendinopathy.
Clinical Pain Advisor Articles
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Stat Consult: Chronic Low Back Pain
- Opioid Misuse May Help Predict Alcohol Dependence Treatment Outcomes
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- FDA Outlines Plan for Increasing Nonprescription Drug Availability
- When Physicians Become Patients: Challenges in Seeking Health Care
- Predictors of Opioid Overdose in High-Risk Users
- FDA to Review Long-Acting Treatment for Opioid Use Disorder
- Half of Patients Referred for Behavioral Treatment of Migraine Never Initiate Treatment